Asset
Indications
Pre-clinical
Phase 1
Phase 2
Phase 3
Approval
Territory
Ohtuvayre™ (ensifentrine)
(Verona)
COPD
China mainland, HK, Macau, Taiwan
AerofactTM
(Aerogen)
Respiratory distress syndrome (RDS)
China mainland, HK, Macau, Taiwan
BentrioTM
(Altamira)
Allergy alleviation/virus prevention nasal spray
China mainland, HK, Macau, Korea
NTM-001
(Neumentum)
POP (post operative pain) 24 hours
China mainland, HK, Macau, Taiwan
ISOKET
(Injectable)
Heart failure, angina, myocardial infarction
China mainland
ISOKET
(Spray)
Heart failure, angina, myocardial infarction
China mainland
ELANTAN
Heart failure, CHD, angina
China mainland
OPRINONE
Heart failure
China mainland
NIFEREX
Iron deficiency anemia
Asia Pac - Trademark across multiple territories